- Report
- January 2026
- 181 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 188 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- February 2026
- 177 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 194 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- October 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- October 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Drug Pipelines
- April 2025
- 180 Pages
Global
From €2190EUR$2,500USD£1,900GBP
- Clinical Trials
- April 2025
- 240 Pages
Global
From €2627EUR$3,000USD£2,280GBP
- Report
- January 2026
- 185 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- November 2025
- 185 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- May 2025
- 196 Pages
Global
From €4160EUR$4,750USD£3,611GBP
- Report
- August 2025
- 136 Pages
Global
From €3502EUR$3,999USD£3,040GBP
- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- October 2025
- 100 Pages
United States
From €5211EUR$5,950USD£4,523GBP
- Report
- July 2025
- 82 Pages
United States
From €3065EUR$3,500USD£2,661GBP
- Report
- May 2025
- 120 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- August 2025
- 183 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 184 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more